ICD-10-CM Billable Code

N01.3

Rapidly progressive nephritic syndrome with diffuse mesangial proliferative glomerulonephritis

Clinical Classification Guidelines

Medical Intelligence & Overview

Rapidly progressive nephritic syndrome (RPS) with diffuse mesangial proliferative glomerulonephritis is a serious kidney condition characterized by rapid deterioration of kidney function due to inflammation of the glomeruli, the tiny filtering units within the kidneys. This condition often progresses swiftly, potentially leading to kidney failure if not diagnosed and treated promptly. It involves the proliferation of mesangial cells within the glomeruli, causing impaired filtration and symptoms like hematuria, proteinuria, and swelling.

Causes & Symptoms

Clinical Causes: Autoimmune diseases, such as systemic lupus erythematosus Infections, including post-infectious glomerulonephritis Certain drugs or toxins that trigger immune responses Underlying unknown factors that lead to immune system dysfunction Genetic predispositions may also contribute

Key Symptoms: Blood in the urine (hematuria) Foamy or dark urine due to protein leakage Swelling in the legs, ankles, or around the eyes (edema) High blood pressure Fatigue and weakness Reduced urine output in advanced cases Fever and malaise may also occur in some instances

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a combination of clinical evaluation and laboratory tests. These may include:

Treatment Protocols: Management of rapidly progressive glomerulonephritis focuses on controlling inflammation and preserving kidney function. Treatment approaches may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N01.3 a billable ICD-10 code?
Yes, N01.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N01.3?
Clinical documentation must specify the nature of Rapidly progressive nephritic syndrome with diffuse mesangial proliferative glomerulonephritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

proliferative rapidly syndrome progressive nephritic glomerulonephritis diffuse mesangial